ArticleAnnals of the New York Academy of Sciences2011
Advancing drug discovery for schizophrenia.
Article in Annals of the New York Academy of Sciences, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 25 citations in OpenAlex.
- PI3Kinase-p110δ Overexpression Impairs Dendritic Morphogenesis and Increases Dendritic Spine Density.Frontiers in molecular neuroscience · 2020Article
- Molecular pharmacology of metabotropic receptors targeted by neuropsychiatric drugs.Nature structural & molecular biology · 2019Review
- Orphan Receptor GPR88 as an Emerging Neurotherapeutic Target.ACS chemical neuroscience · 2019Review
- Chemistry-based molecular signature underlying the atypia of clozapine.Translational psychiatry · 2017Article
- Behavioral, Neurophysiological, and Synaptic Impairment in a Transgenic Neuregulin1 (NRG1-IV) Murine Schizophrenia Model.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2016Article
- Role of social factors on cell death, cerebral plasticity and recovery after stroke.Metabolic brain disease · 2015Review
- ΔFosB induction in prefrontal cortex by antipsychotic drugs is associated with negative behavioral outcomes.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2014Article
- Schizophrenia research in 2013: are we making progress?Neurobiology of disease · 2013Article
- GABAergic neuroactive steroids: a new frontier in bipolar disorders?Behavioral and brain functions : BBF · 2012Review
- DISC1 as a therapeutic target for mental illnesses.Expert opinion on therapeutic targets · 2012Review
- Effect of valproic acid on mitochondrial epigenetics.European journal of pharmacology · 2012Article
- Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings.Journal of neurodevelopmental disorders · 2012Article
Corrections and comments
- Erratum issuedSaw, Akira [corrected to Sawa, Akira]
Authors and funding
25 authors at 15 institutions in 2 countries.
Funding
Abstract
Sponsored by the New York Academy of Sciences and with support from the National Institute of Mental Health, the Life Technologies Foundation, and the Josiah Macy Jr. Foundation, "Advancing Drug Discovery for Schizophrenia" was held March 9-11 at the New York Academy of Sciences in New York City. The meeting, comprising individual talks and panel discussions, highlighted basic, clinical, and translational research approaches, all of which contribute to the overarching goal of enhancing the pharmaceutical armamentarium for treating schizophrenia. This report surveys work by the vanguard of schizophrenia research in such topics as genetic and epigenetic approaches; small molecule therapeutics; and the relationships between target genes, neuronal function, and symptoms of schizophrenia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.